000 01443 a2200385 4500
005 20250514200034.0
264 0 _c20041110
008 200411s 0 0 eng d
022 _a0193-953X
024 7 _a10.1016/j.psc.2004.03.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSimon, Asher
245 0 0 _aPsychopharmacological possibilities in the acute disaster setting.
_h[electronic resource]
260 _bThe Psychiatric clinics of North America
_cSep 2004
300 _a425-58 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAcute Disease
650 0 4 _aAmygdala
_xmetabolism
650 0 4 _aCognition Disorders
_xepidemiology
650 0 4 _aCorticotropin-Releasing Hormone
_xmetabolism
650 0 4 _aDisasters
650 0 4 _aGlutamic Acid
_xmetabolism
650 0 4 _aHippocampus
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMemory Disorders
_xepidemiology
650 0 4 _aNeurotransmitter Agents
_xmetabolism
650 0 4 _aNorepinephrine
_xmetabolism
650 0 4 _aPrefrontal Cortex
_xmetabolism
650 0 4 _aPsychopharmacology
_xclassification
650 0 4 _aReceptors, N-Methyl-D-Aspartate
_xmetabolism
650 0 4 _aStress Disorders, Post-Traumatic
_xdrug therapy
700 1 _aGorman, Jack
773 0 _tThe Psychiatric clinics of North America
_gvol. 27
_gno. 3
_gp. 425-58
856 4 0 _uhttps://doi.org/10.1016/j.psc.2004.03.004
_zAvailable from publisher's website
999 _c15023393
_d15023393